Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
36
IXJ Quote, Financials, Valuation and Earnings
Last price:
$97.08
Seasonality move
:
1.37%
Day range:
$98.46 - $99.61
52-week range:
$80.68 - $101.78
Dividend yield:
1.37%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
84.7K
Avg. volume:
451.1K
1-year change:
6.75%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IXJ
iShares Global Healthcare ETF
|
$99.37 | -- | -- | -- | $0.60 | 1.37% | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
$89.84 | -- | -- | -- | $0.59 | 1.67% | -- |
|
IYH
iShares US Healthcare ETF
|
$65.51 | -- | -- | -- | $0.25 | 1.18% | -- |
|
PPH
VanEck Pharmaceutical ETF
|
$108.84 | -- | -- | -- | $0.31 | 1.69% | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
$290.24 | -- | -- | -- | $1.67 | 1.6% | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
$157.05 | -- | -- | -- | $0.66 | 1.58% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IXJ
iShares Global Healthcare ETF
|
-- | -0.024 | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -0.088 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -0.054 | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.069 | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | 0.000 | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -0.144 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- | -- |
iShares Global Healthcare ETF vs. Competitors
-
Which has Higher Returns IXJ or IHE?
iShares US Pharmaceuticals ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- -
What do Analysts Say About IXJ or IHE?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe iShares Global Healthcare ETF is more attractive than iShares US Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 IHEiShares US Pharmaceuticals ETF0 0 0 -
Is IXJ or IHE More Risky?
iShares Global Healthcare ETF has a beta of 0.676, which suggesting that the stock is 32.433% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.554, suggesting its less volatile than the S&P 500 by 44.628%.
-
Which is a Better Dividend Stock IXJ or IHE?
iShares Global Healthcare ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.37%. iShares US Pharmaceuticals ETF offers a yield of 1.67% to investors and pays a quarterly dividend of $0.59 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or IHE?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns IXJ or IYH?
iShares US Healthcare ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About IXJ or IYH?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than iShares US Healthcare ETF, analysts believe iShares Global Healthcare ETF is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is IXJ or IYH More Risky?
iShares Global Healthcare ETF has a beta of 0.676, which suggesting that the stock is 32.433% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.680, suggesting its less volatile than the S&P 500 by 31.972%.
-
Which is a Better Dividend Stock IXJ or IYH?
iShares Global Healthcare ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.37%. iShares US Healthcare ETF offers a yield of 1.18% to investors and pays a quarterly dividend of $0.25 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or IYH?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
-
Which has Higher Returns IXJ or PPH?
VanEck Pharmaceutical ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat VanEck Pharmaceutical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- PPHVanEck Pharmaceutical ETF-- -- -- -
What do Analysts Say About IXJ or PPH?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Pharmaceutical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than VanEck Pharmaceutical ETF, analysts believe iShares Global Healthcare ETF is more attractive than VanEck Pharmaceutical ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 PPHVanEck Pharmaceutical ETF0 0 0 -
Is IXJ or PPH More Risky?
iShares Global Healthcare ETF has a beta of 0.676, which suggesting that the stock is 32.433% less volatile than S&P 500. In comparison VanEck Pharmaceutical ETF has a beta of 0.560, suggesting its less volatile than the S&P 500 by 44.036%.
-
Which is a Better Dividend Stock IXJ or PPH?
iShares Global Healthcare ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.37%. VanEck Pharmaceutical ETF offers a yield of 1.69% to investors and pays a quarterly dividend of $0.31 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. VanEck Pharmaceutical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or PPH?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than VanEck Pharmaceutical ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than VanEck Pharmaceutical ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while VanEck Pharmaceutical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for VanEck Pharmaceutical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- PPHVanEck Pharmaceutical ETF-- -- -- --
-
Which has Higher Returns IXJ or VHT?
Vanguard Health Care Index Fund ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat Vanguard Health Care Index Fund ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- -
What do Analysts Say About IXJ or VHT?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Vanguard Health Care Index Fund ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than Vanguard Health Care Index Fund ETF, analysts believe iShares Global Healthcare ETF is more attractive than Vanguard Health Care Index Fund ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 VHTVanguard Health Care Index Fund ETF0 0 0 -
Is IXJ or VHT More Risky?
iShares Global Healthcare ETF has a beta of 0.676, which suggesting that the stock is 32.433% less volatile than S&P 500. In comparison Vanguard Health Care Index Fund ETF has a beta of 0.701, suggesting its less volatile than the S&P 500 by 29.881%.
-
Which is a Better Dividend Stock IXJ or VHT?
iShares Global Healthcare ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.37%. Vanguard Health Care Index Fund ETF offers a yield of 1.6% to investors and pays a quarterly dividend of $1.67 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. Vanguard Health Care Index Fund ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or VHT?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than Vanguard Health Care Index Fund ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than Vanguard Health Care Index Fund ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while Vanguard Health Care Index Fund ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for Vanguard Health Care Index Fund ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- --
-
Which has Higher Returns IXJ or XLV?
State Street Health Care Select Sector SPDR ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat State Street Health Care Select Sector SPDR ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- -
What do Analysts Say About IXJ or XLV?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street Health Care Select Sector SPDR ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than State Street Health Care Select Sector SPDR ETF, analysts believe iShares Global Healthcare ETF is more attractive than State Street Health Care Select Sector SPDR ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 XLVState Street Health Care Select Sector SPDR ETF0 0 0 -
Is IXJ or XLV More Risky?
iShares Global Healthcare ETF has a beta of 0.676, which suggesting that the stock is 32.433% less volatile than S&P 500. In comparison State Street Health Care Select Sector SPDR ETF has a beta of 0.660, suggesting its less volatile than the S&P 500 by 33.982%.
-
Which is a Better Dividend Stock IXJ or XLV?
iShares Global Healthcare ETF has a quarterly dividend of $0.60 per share corresponding to a yield of 1.37%. State Street Health Care Select Sector SPDR ETF offers a yield of 1.58% to investors and pays a quarterly dividend of $0.66 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. State Street Health Care Select Sector SPDR ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or XLV?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than State Street Health Care Select Sector SPDR ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than State Street Health Care Select Sector SPDR ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while State Street Health Care Select Sector SPDR ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for State Street Health Care Select Sector SPDR ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is down 7.15% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is down 6.83% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is down 6.13% over the past day.
